Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 Sep 26;283(6295):825–826. doi: 10.1136/bmj.283.6295.825

Toxic hepatis during ketoconazole treatment.

J K Heiberg, E Svejgaard
PMCID: PMC1507043  PMID: 6271328

Full text

PDF
825

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hay R. J., Wells R. S., Clayton Y. M., Wingfield H. J. Treatment of chronic mucocutaneous candidosis with ketoconazole: a study of 12 cases. Rev Infect Dis. 1980 Jul-Aug;2(4):600–605. doi: 10.1093/clinids/2.4.600. [DOI] [PubMed] [Google Scholar]
  2. Petersen E. A., Alling D. W., Kirkpatrick C. H. Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. Ann Intern Med. 1980 Dec;93(6):791–795. doi: 10.7326/0003-4819-93-6-791. [DOI] [PubMed] [Google Scholar]
  3. Razzouk C., Agazzi-Léonard E., Cumps J., Poncelet F., Mercier M., Roberfroid M. Induction, modification and inhibition of rat liver microsomal benzo(a)pyrene hydroxylase; correlation with the S-9-mediated mutagenicity of benzo(a)pyrene. Biochem Biophys Res Commun. 1978 Dec 14;85(3):1007–1016. doi: 10.1016/0006-291x(78)90643-5. [DOI] [PubMed] [Google Scholar]
  4. Robertson M. H., Hanifin J. M., Parker F. Oral therapy with ketoconazole for dermatophyte infections unresponsive to griseofulvin. Rev Infect Dis. 1980 Jul-Aug;2(4):578–581. doi: 10.1093/clinids/2.4.578. [DOI] [PubMed] [Google Scholar]
  5. Symoens J., Moens M., Dom J., Scheijgrond H., Dony J., Schuermans V., Legendre R., Finestine N. An evaluation of two years of clinical experience with ketoconazole. Rev Infect Dis. 1980 Jul-Aug;2(4):674–687. doi: 10.1093/clinids/2.4.674. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES